Loading data for DMAA — first visit, this takes a few seconds.
Drugs Made In America Acquisition Corp. (DMAA)
NasdaqGM: DMAA
· 即時價格 · USD
10.75
-0.01 (-0.09%)
收盤價： Sep 02, 2026, 3:36 PM
股價、關鍵數字和最新消息，都在這一頁。
Drugs Made In America Acquisition Corp.（DMAA）股價、分析與資料
-0.09% (1D)
| 買價 | 10.65 |
| 市值 | 261M |
| 營收 (ttm) | n/a |
| 淨利（ttm） | 6.09M |
| 0.00 | |
| 0.18 | |
| 59.72 | |
| n/a | |
| P/B (ttm) | -35.25 |
| P/S (ttm) | 0.00 |
| 財報日期 | n/a |
| 賣價 | 10.54 |
| 成交量 | 109 |
| 20 日平均成交量 | 26,524 |
| 開盤價 | 10.75 |
| 前收盤價 | 10.76 |
| 當日區間 | 10.75 - 10.75 |
| 52 週範圍 | 10.23 - 10.77 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 DMAA
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York....
完整的公司簡介財務表現
Drugs Made In America Acquisition 在 2025 年的營收為 0，較前一年的 n/a 增加 undefined%。 淨利為 5.94M，較前期增加 undefined%。
財務報表財報驚奇
Drugs Made In America Acquisition 已於 Invalid Date 公布季度財報：
- 營收為 n/a 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 低於預期 , 年增 NaN% 成長.
